RYTM - Rhythm Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RYTM is currently covered by 11 analysts with an average price target of $82.83. This is a potential upside of $16.65 (25.16%) from yesterday's end of day stock price of $66.18.

Rhythm Pharmaceuticals's activity chart (see below) currently has 69 price targets and 108 ratings on display. The stock rating distribution of RYTM is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.16% with an average time for these price targets to be met of 363 days.

Highest price target for RYTM is $92, Lowest price target is $65, average price target is $74.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 07-May-2025. First documented stock forecast 30-Oct-2017.

Currently out of the existing stock ratings of RYTM, 55 are a BUY (91.67%), 5 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$72

$10.67 (17.40%)

$66

29 days ago
(07-May-2025)

18/21 (85.71%)

$7.37 (11.40%)

117

Buy

$68

$6.67 (10.88%)

$63

1 months 26 days ago
(10-Apr-2025)

12/13 (92.31%)

$10.17 (17.59%)

163

Buy

$92

$30.67 (50.01%)

$81

1 months 28 days ago
(08-Apr-2025)

2/8 (25%)

$34.27 (59.36%)

502

Buy

$80

$18.67 (30.44%)

$70

1 months 28 days ago
(08-Apr-2025)

3/10 (30%)

$22.27 (38.58%)

33

Buy

$91

$29.67 (48.38%)

$52

1 months 29 days ago
(07-Apr-2025)

11/12 (91.67%)

$36.04 (65.57%)

364

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?

On average it took 363 days on average for the stock forecasts to be realized with a an average price target met ratio 72.16

Which analyst has the current highest performing score on RYTM (Rhythm Pharmaceuticals) with a proven track record?

WHITNEY IJEM

Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?

Whitney Ijem works at CANACCORD and has 19 price targets and 13 ratings on RYTM

Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?

Whitney Ijem with highest potential upside - $30.67

Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?

Graig Suvannavejh with lowest potential downside - -$50.69

Rhythm Pharmaceuticals in the News

Rhythm Pharmaceuticals Inc (RYTM) Q1 2025 Earnings Call Highlights: Strong IMCIVREE Sales and ...

Revenue: $37.7 million from global sales of IMCIVREE in Q1 2025. Patient Growth: 14% increase in the number of patients on reimbursed therapy globally during the quarter. Inventory Impact: $8.3 million inventory swing at the specialty pharmacy in the US, affecting revenue. Net Revenue Change: Decrease of $4.1 million compared to Q4 2024 due to...

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for

Wave Life Sciences (WVE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company’s earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?